These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Characteristics of the disordered regulation of monoamine oxidase activity in pathological states and the regulatory role of the monoamine oxidases]. Gorkin VZ Vestn Akad Med Nauk SSSR; 1986; (8):8-13. PubMed ID: 3532612 [No Abstract] [Full Text] [Related]
5. [Tribulin--a novel endogenous monoaminoxidase inhibitor (dedicated to the memory of Merton Sandler)]. Medvedev AR Vopr Med Khim; 1996; 42(2):95-103. PubMed ID: 9148606 [TBL] [Abstract][Full Text] [Related]
6. Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead. Tipton KF; Davey GP; McDonald AG Int Rev Neurobiol; 2011; 100():43-64. PubMed ID: 21971002 [TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase and their inhibitors. Preface. Int Rev Neurobiol; 2011; 100():xi-xv. PubMed ID: 21971011 [No Abstract] [Full Text] [Related]
8. Abstracts from the symposium Monoamine oxidase and disease: prospects for therapy with reversible inhibitors. Paris, October 26-28, 1983. Encephale; 1983; 9(2 Suppl 1):1A-98A. PubMed ID: 6641619 [No Abstract] [Full Text] [Related]
9. [Behavior of monoamine oxidase in the brain of man after therapy with monoamine oxidase inhibitors]. BERNHEIMER H; BIRKMAYER W; HORNYKIEWICZ O Wien Klin Wochenschr; 1962 Aug; 74():558-9. PubMed ID: 13868185 [No Abstract] [Full Text] [Related]
10. Structural aspects of monoamine oxidase and its reversible inhibition. Wouters J Curr Med Chem; 1998 Apr; 5(2):137-62. PubMed ID: 9481038 [TBL] [Abstract][Full Text] [Related]
11. Structure-Based Specific Detection and Inhibition of Monoamine Oxidases and Their Applications in Central Nervous System Diseases. Shi R; Wu Q; Xin C; Yu H; Lim KL; Li X; Shi Z; Zhang CW; Qian L; Li L; Huang W Chembiochem; 2019 Jun; 20(12):1487-1497. PubMed ID: 30664830 [TBL] [Abstract][Full Text] [Related]
12. Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases. Rahman T; Rahmatullah M Bioorg Med Chem Lett; 2010 Jan; 20(2):537-40. PubMed ID: 19969454 [TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase? Sandler M; Glover V; Clow A; Jarman J Adv Neurol; 1993; 60():238-41. PubMed ID: 8420141 [No Abstract] [Full Text] [Related]
14. [Mechanism of the pharmacological effect of monoamine oxidase inhibitors]. Gorkin VZ Vestn Akad Med Nauk SSSR; 1984; (11):72-5. PubMed ID: 6396999 [No Abstract] [Full Text] [Related]
17. A neuroscientific update on monoamine oxidase and its inhibitors. Schwartz TL CNS Spectr; 2013 Dec; 18 Suppl 1():25-32; quiz 33. PubMed ID: 24252505 [TBL] [Abstract][Full Text] [Related]
18. Tetrahydropapaveroline in Parkinson's disease and alcoholism: a look back in honor of Merton Sandler. Collins MA Neurotoxicology; 2004 Jan; 25(1-2):117-20. PubMed ID: 14697886 [TBL] [Abstract][Full Text] [Related]
19. [Amine oxidases]. Levy L Therapie; 1968; 23(5):1003-36. PubMed ID: 4883547 [No Abstract] [Full Text] [Related]